Format

Send to

Choose Destination
Eur Heart J. 2014 Apr;35(14):883-7. doi: 10.1093/eurheartj/eht467. Epub 2013 Nov 11.

The gut microbiome as novel cardio-metabolic target: the time has come!

Author information

1
Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, AMC-UvA, Meibergdreef 9, room F4-159.2, 1105 AZ Amsterdam, The Netherlands.

Abstract

Recent studies reveal a potential contribution of intestinal microbes in the expression of certain human cardio-metabolic diseases. The mechanisms through which intestinal microbiota and/or their metabolic products alter systemic homoeostasis and cardio-metabolic disease risks are just beginning to be dissected. Intervention studies in humans aiming to either selectively alter the composition of the intestinal microbiota or to pharmacologically manipulate the microbiota to influence production of their metabolites are crucial next steps. The intestinal microbiome represents a new potential therapeutic target for the treatment of cardio-metabolic diseases.

KEYWORDS:

Atherothrombosis; Gutmicrobiota; Insulin resistance; Obesity; TMAO; Therapy; Vascular inflammation

PMID:
24216389
PMCID:
PMC3977135
DOI:
10.1093/eurheartj/eht467
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center